Levels of glial fibrillary acidic protein (GFAP), an astrocyte-specific intermediate filament protein, are altered during development and aging, GFAP also responds dynamically to neurodegenerative lesions. Changes in GFAP expression can occur at both transcriptional and translational levels. Modulators of GFAP expression include steroids, cytokines, and growth factors. GFAP expression also shows brain region-specific responses to sex steroids and of astrocyte-neuronal interactions. The 5'-upstream sequences of rat, mouse, and human are compared for the presence of response elements that are candidates for transcriptional regulation of GFAP. We propose that the regulation of the GFAP gene has evolved a system of controls that allow integrated responses to neuroendocrine and inflammatory modulators.
TGF-PI mRNA and protein were recently found to increase in animal brains after experimental lesions that cause local deafferentation or neuron death. Elevations of TGF-PI mRNA after lesions are prominent in microglia but are also observed in neurons and astrocytes. Moreover, TGF-PI mRNA autoinduces its own mRNA in the brain. These responses provide models for studying the increases of TGF-PI protein observed in PAiamyloid-containing extracellular plaques of Alzheimer's disease (AD) and Down's syndrome (DS) and in brain cells of AIDS victims.Involvement of TGF-01 in these human brain disorders is discussed in relation to the potent effects of TGF-PI on wound healing and inflammatory responses in peripheral tissues.We hypothesize that TGF-PI and possibly other TGF-P peptides have organizing roles in responses to neurodegeneration and brain injury that are similar to those observed in non-neural tissues. Work from many laboratories has shown that activities of TGF-P peptides on brain cells include chemotaxis, modification of extracellular matrix, and regulation of cytoskeletal gene expression and of neurotrophins. Similar activities of the TGF-P's are well established in other tissues.
Epidemiological studies suggest that multiple developmental disruptions are involved in the etiology of psychiatric illnesses including schizophrenia. In addition, altered expression of brain-derived neurotrophic factor (BDNF) has been implicated in these illnesses. In the present study, we examined the combined long-term effect of an early stress, in the form of maternal deprivation, and a later stress, simulated by chronic young-adult treatment with the stress hormone, corticosterone, on BDNF expression in the hippocampus of rats. To assess whether there were behavioral effects, which may correlate with the BDNF changes, learning and memory was tested in the Y-maze test for short term spatial memory, the Morris water maze for long-term spatial memory, and the T-maze test for working memory. Four groups of rats received either no stress, maternal deprivation, corticosterone treatment, or both. Dorsal hippocampus sections obtained from parallel groups were used for BDNF mRNA in situ hybridization. Rats which had undergone both maternal deprivation and corticosterone treatment displayed a unique and significant 25-35% reduction of BDNF expression in the dentate gyrus (DG), and similar trends in the CA1 and CA3 regions of the hippocampus. These "two-hit" animals exhibited a learning delay in the Morris water maze test, a marked deficit in the Y-maze, but little change in the T-maze test. However, some aspects of cognition were also altered in rats with either maternal deprivation or corticosterone treatment. This study demonstrates a persistent effect of two developmental disruptions on BDNF expression in the hippocampus, with parallel, but not completely correlative changes in learning and memory.
Ongoing production of neurons in adult brain is restricted to specialized neurogenic niches. Deregulated expression of genes controlling homeostasis of neural progenitor cell division and/or their microenvironment underpins a spectrum of brain pathologies. Using conditional gene deletion, we show that the proto-oncogene c-myb regulates neural progenitor cell proliferation and maintains ependymal cell integrity in mice. These two cellular compartments constitute the neurogenic niche in the adult brain. Brains devoid of c-Myb showed enlarged ventricular spaces, ependymal cell abnormalities, and reduced neurogenesis. Neural progenitor cells lacking c-Myb showed a reduced intrinsic proliferative capacity and reduction of Sox-2 and Pax-6 expression. These data point to an important role for c-Myb in the neurogenic niche of the adult brain. STEM CELLS 2008;26:173-181 Disclosure of potential conflicts of interest is found at the end of this article.
Previously, we cloned a gene from rat hippocampus that now shows homology to Ndrg2, a member of the N-myc downregulated gene (NDRG) family with putative roles in neural differentiation, synapse formation, and axon survival. Following adrenalectomy, hippocampal Ndrg2 mRNA increased in response to glucocorticoids. Ndrg2 mRNA was also upregulated by corticosterone in cerebral cortex and heart. Since Ndrg2 mRNA increased in response to glucocorticoid treatment of cultured astrocytes, we examined its cellular localization in adult brain by in situ hybridization. Ndrg2 mRNA is a prevalent message that is widely expressed throughout the brain, but is more abundant in gray matter than in white matter. Predominant mRNA expression was found in neurogenic regions of the adult brain. Furthermore, Ndrg2 mRNA in these regions was localized to GFAP-positive astrocytes or radial glia. In one of these regions, the subgranular zone of the dentate gyrus, Ndrg2 expression was decreased after adrenalectomy, and was restored to sham-operated levels by corticosterone, indicating that it is under positive regulation by glucocorticoids in vivo. Recently, another group reported that Ndr2/Ndrg2 transcripts in rat frontal cortex were decreased by chronic antidepressant treatment. Because antidepressants may alleviate symptoms of depression by reversing the effects of glucocorticoids, these data suggest that further study of Ndrg2 regulation and function in glia could contribute to understanding the pathogenesis and treatment of depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.